Navigation Links
GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013
Date:5/14/2013

LONDON, May 14, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will be announcing interim financial results for the six months ended 31 March 2013 on Monday, 3 June 2013, prior to the UK stock market open. GW will also host a conference call the same day at 1:00 p.m. BST (8:00 a.m. EDT). GW is currently in a "quiet period" due to the Company's recent Initial Public Offering of American Depository Shares on the Nasdaq Capital Market exchange and has decided to hold its Interim results presentation after the expiration of this quiet period.

Conference call information will be provided in the interim financial results press release. A replay of the call will also be available through the Company's website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 21 countries. Sativex is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW has established a world leading position in the development of plant-derived cannabinoid therapeutics and has a deep pipeline of additional cannabinoid product candidates, including two distin
'/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... HILL, S.C. , Sept. 18, 2014   3D ... addition of the Simbionix RobotiX Mentor™ , a new ... shown for the first time at the ERUS exhibition in ... to 19 (booth #7). Robotic-assisted minimally invasive surgery ... increased demand means the needs for training for robotic surgery ...
(Date:9/18/2014)... , Sept. 18, 2014 Veterinary biologic ... Dr. Ashraf Hanna , M.D., Ph.D., and Dr. ... of Directors. Dr. Hanna is the Vice President of ... Financial Officer for the Genentech Foundation, while Dr. McCracken ... of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
Breaking Medicine Technology:3D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... MYRTLE BEACH, S.C., Sept. 19, 2011 Laser ... has received an FDA approval for its revolutionary laser ... treats pain through nerve tissue regeneration. ... trigeminal nerve in the face. The trigeminal nerve (the ...
... 19, 2011 Bayer HealthCare, one of the world,s ... to support the Women,s International Leadership (WIL) Program at ... that Bayer HealthCare has established as part of its ... to further develop an environment that fosters the development ...
Cached Medicine Technology:FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment 2International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions 2International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions 3
(Date:9/18/2014)... that elderly men should not be routinely screened for ... a new study led by researchers at Henry Ford ... in JAMA Internal Medicine , focused on the ... for prostate cancer., "We found that the effect of ... men in particular has been minimal at best," says ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 ChopChop ... Bill Yosses and Yonah Kalikow, 10-year-old Massachusetts’s winner of the ... twist on hummus, the classic Middle Eastern bean dip. Watch ... stage how kids can create their own healthy dips at ... at the third annual Let’s Talk About Food Festival ...
(Date:9/18/2014)... Technology Association of Georgia in collaboration with TAG ... Savvy Awards this week at a special ceremony held ... Downtown Atlanta. The event celebrates Georgia’s best and brightest ... with the 2014 TAG Social Savvy People’s Choice Award ... 6 other award categories: , ,     UPS ...
(Date:9/18/2014)... 18, 2014 Once again, Hickman’s Family ... restaurants around the Valley to celebrate PJs & Eggs. ... Egg Day”: Friday, October 10, 2014. The “breakfast for ... to benefit Arizona’s Children Association (AzCA) foster care programs ... at each participating restaurant on October 10 are invited ...
(Date:9/18/2014)... cancer-hampering molecules show promise in slowing the progression ... often linked to asbestos. Scientists from Case Western ... demonstrate that application of curcumin, a derivative of ... of a protein inhibitor known to combat the ... the Aug. 14 online edition Clinical Cancer ...
Breaking Medicine News(10 mins):Health News:Professional recommendations against routine prostate cancer screening have little effect 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 3Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 3
... The most common form of thalassaemia disease may ... ,Hemoglobin E ? thalassaemia—the commonest form of ... without transfusion in many patients, suggests a research ... The Lancet. The authors state that the finding ...
... of researchers at Vienna University have said they are ... it will be effective against lung cancer//. , ... much more research was still needed before the new ... statement Tuesday. , ,"In fact it's a paradox," ...
... to complex problems lies at hand but that is the ... new anti obesity drug//. A weight control protein with a ... content may yield new approaches for treating obesity and type ... particular variants of the protein SH2-B might underlie obesity in ...
... found a new protein which may be responsible for the ... is known as MSF protein is produced in high quantity ... produced may be responsible for the severity of disease progression. ... protein, the scientists are looking into the properties of these ...
... vulnerable to suffer from the dreaded disease of multiple ... risk//. ,According to the most complete genetic study ... from Vanderbilt University in Nashville, Tennessee at the 130th ... Diego, a cluster of genes on chromosome six is ...
... research report published in the latest issue of Archives ... ready to deal with the threat of bio-terrorism that ... ,More than one-half of 631 physicians tested were ... likely to be used by bio-terrorists. However, test scores ...
Cached Medicine News:Health News:Flu Vaccine Can Be Used To Treat Lung Cancer 2Health News:An Answer To Obesity: Weight Control Protein 2
Caspar Curette, 250 mm, 10"....
Bone Curette, 160 mm...
Bone Curette, 145 mm...
Bone Currettes...
Medicine Products: